The Korea Economic Daily says the domestic obesity drug starts at roughly half of Mounjaro's starting price, a new low-cost option for patients in Korea.
Recap by typeshit. Post by The Korea Economic Daily on X.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
BusinessWorld Online lists a new FDA warning covering weight loss drugs such as Wegovy. The listing doesn't say what the warning is about, so check the source for details.
On India Today, the two weighed the benefits of GLP-1 medicines against misuse, with concerns raised about cosmetic use for weight loss.
Loading…